Abbreviations

The GLIOMATCH project has officially started in January 2024

January 1, 2024

Under the coordination of KU Leuven, the consortium of partners from diverse disciplines, including clinical experts, medical practitioners, data scientists, and health economists, will be working on pioneering personalised therapies for brain cancer patients.

More Posts

GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany

On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.

International Day of Women and Girls in Science 2025

On the 10th anniversary of the International Day of Women and Girls in Science, GLIOMATCH celebrates the women driving our research and our commitment to gender balance in science and leadership.

World Cancer Day 2025

On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.

GLIOMATCH Receives Ethical Approval for Retrospective Clinical Trials

The GLIOMATCH project has received ethical approval from the UZ/KU Leuven Ethics Committee to conduct retrospective clinical trials for adult and paediatric glioma patients. This follows earlier approvals for other project partners, setting data collection to begin in 2025,.